Larimar Therapeutics to Present at the Leerink Partners Global Healthcare Conference
Larimar Therapeutics (Nasdaq: LRMR), a clinical-stage biotechnology company specializing in complex rare disease treatments, has announced its participation in the upcoming Leerink Partners Global Healthcare Conference in Miami Beach, FL.
The company's management team will deliver a presentation on Monday, March 10, 2025, from 3:40 to 4:10 PM EST and engage in one-on-one investor meetings throughout the conference, which runs from March 10-12, 2025. The presentation will be accessible via webcast, and a replay will remain available for 30 days on Larimar's website under the 'Events and Presentations' section.
Larimar Therapeutics (Nasdaq: LRMR), un'azienda biotecnologica in fase clinica specializzata nel trattamento di malattie rare complesse, ha annunciato la sua partecipazione alla prossima Conferenza Globale sulla Salute di Leerink Partners a Miami Beach, FL.
Il team di gestione dell'azienda presenterà un intervento lunedì 10 marzo 2025, dalle 15:40 alle 16:10 EST e parteciperà a incontri individuali con gli investitori durante la conferenza, che si svolgerà dal 10 al 12 marzo 2025. La presentazione sarà accessibile tramite webcast e una registrazione rimarrà disponibile per 30 giorni sul sito web di Larimar nella sezione 'Eventi e Presentazioni'.
Larimar Therapeutics (Nasdaq: LRMR), una empresa de biotecnología en etapa clínica especializada en tratamientos para enfermedades raras complejas, ha anunciado su participación en la próxima Conferencia Global de Salud de Leerink Partners en Miami Beach, FL.
El equipo de gestión de la empresa presentará una exposición el lunes 10 de marzo de 2025, de 3:40 a 4:10 PM EST y participará en reuniones individuales con inversores durante la conferencia, que se llevará a cabo del 10 al 12 de marzo de 2025. La presentación será accesible a través de un webcast y una grabación estará disponible durante 30 días en el sitio web de Larimar en la sección 'Eventos y Presentaciones'.
Larimar Therapeutics (Nasdaq: LRMR)는 복잡한 희귀 질환 치료를 전문으로 하는 임상 단계의 생명공학 회사로, 플로리다주 마이애미 비치에서 열리는 Leerink Partners 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다.
회사의 경영진은 2025년 3월 10일 월요일, 오후 3시 40분부터 4시 10분 EST까지 발표를 진행하며, 컨퍼런스 기간 동안 투자자와의 일대일 미팅에 참여할 예정입니다. 발표는 웹캐스트를 통해 접근 가능하며, Larimar 웹사이트의 '이벤트 및 발표' 섹션에서 30일 동안 재생할 수 있습니다.
Larimar Therapeutics (Nasdaq: LRMR), une entreprise de biotechnologie en phase clinique spécialisée dans le traitement de maladies rares complexes, a annoncé sa participation à la prochaine Conférence Mondiale sur la Santé de Leerink Partners à Miami Beach, FL.
L'équipe de direction de l'entreprise présentera une intervention le lundi 10 mars 2025, de 15h40 à 16h10 EST et participera à des réunions individuelles avec des investisseurs tout au long de la conférence, qui se déroulera du 10 au 12 mars 2025. La présentation sera accessible via un webcast, et un enregistrement sera disponible pendant 30 jours sur le site web de Larimar dans la section 'Événements et Présentations'.
Larimar Therapeutics (Nasdaq: LRMR), ein biopharmazeutisches Unternehmen in der klinischen Entwicklungsphase, das sich auf Behandlungen seltener komplexer Erkrankungen spezialisiert hat, hat seine Teilnahme an der bevorstehenden Leerink Partners Global Healthcare Conference in Miami Beach, FL, bekannt gegeben.
Das Management-Team des Unternehmens wird am Montag, den 10. März 2025, von 15:40 bis 16:10 Uhr EST eine Präsentation halten und während der Konferenz, die vom 10. bis 12. März 2025 stattfindet, Einzelgespräche mit Investoren führen. Die Präsentation wird über einen Webcast zugänglich sein und eine Aufzeichnung wird für 30 Tage auf der Website von Larimar im Abschnitt 'Veranstaltungen und Präsentationen' verfügbar sein.
- None.
- None.
BALA CYNWYD, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that members of the company’s management team will present and participate in 1x1 investor meetings at the Leerink Partners Global Healthcare Conference, taking place in Miami Beach, FL from March 10 – 12, 2025.
Details on the presentation can be found below.
Date: Monday, March 10, 2025
Time: 3:40 – 4:10 PM EST
Webcast Link: https://wsw.com/webcast/leerink38/lrmr/2247553
Following the conclusion of the presentation, a replay will be available for 30 days on the “Events and Presentations” page of Larimar’s website.
About Larimar Therapeutics
Larimar Therapeutics, Inc. (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. Larimar’s lead compound, nomlabofusp, is being developed as a potential treatment for Friedreich's ataxia. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. For more information, please visit: https://larimartx.com.
Investor Contact:
Joyce Allaire
LifeSci Advisors
jallaire@lifesciadvisors.com
(212) 915-2569
Company Contact:
Michael Celano
Chief Financial Officer
mcelano@larimartx.com
(484) 414-2715
FAQ
When is Larimar Therapeutics (LRMR) presenting at the Leerink Partners Conference 2025?
How can investors watch Larimar Therapeutics' (LRMR) Leerink Conference presentation?
What type of meetings will LRMR management conduct at the 2025 Leerink Conference?
How long will the LRMR Leerink Conference presentation replay be available?
